Table 5 Group V, cases diagnosed with other malignant neoplasms
From: Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
Case no. | HER2/neu | Primary site | Histopathology diagnosis | ||||
|---|---|---|---|---|---|---|---|
IHC | FISH | Result | Type | FIGO | Nuc | ||
1 | 3+ | 3.5 | POS | Endometrium | UnDiff | 3 | 3 |
2 | 0 | NP | NEG | Endometrium | UnDiff | 3 | 3 |
3 | 1+ | NP | NEG | Endometrium | UnDiff | 3 | 3 |
4 | NP | 1 | NEG | Endometrium | UnDiff | 3 | 3 |
5 | 0 | NP | NEG | Ovary | MMMT | NA | NA |
6 | 0 | 1.54 | NEG | Endometrium | MMMT | NA | NA |
7 | 0 | NP | NEG | Endometrium | MMMT | NA | NA |
8 | 1+ | NP | NEG | Endometrium | MMMT | NA | NA |
9 | 1+ | NP | NEG | Pelvic Mass | MMMT | NA | NA |
10 | 1+ | 1 | NEG | Endometrium | MMMT | NA | NA |
11 | 1+ | NP | NEG | Ovary | MMMT | NA | NA |
12 | 0 | NP | NEG | Endometrium | ESS | NA | NA |
13 | 0 | NP | NEG | Endometrium | ESS | NA | NA |
14 | 1+ | NP | NEG | Cervix | ECAdCA | 1 | 1 |
15 | 0 | NP | NEG | Ovary | Yolk Sac Tumor | NA | NA |